{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:06:20Z","timestamp":1760043980327,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Primary effusion lymphoma is a rare, high-grade non-Hodgkin\u2019s lymphoma that usually occurs in immunosuppressed or human immunodeficiency virus-positive individuals in advanced stages of the disease. However, primary effusion lymphoma occasionally affects immunocompetent patients who are infected with human herpes virus type 8 or Epstein-Barr virus. This disease manifests with liquid collections in cavities, producing constitutional symptoms; fever; weight loss; and symptoms related to extrinsic compression, such as dyspnea or abdominal discomfort. Diagnosis is confirmed with cytological or tissue evaluation showing large, multinucleated lymphoid cells with positive specific markers for the disease, such as CD45 and markers related to viral infections, when present. There is no standard treatment for primary effusion lymphoma, but several chemotherapy protocols are recommended, usually with poor results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present a case of an adult human immunodeficiency virus-negative Hispanic origin woman with primary effusion lymphoma with pleuritic, pericardial, and peritoneal compromise who also had unusual complications during a diagnostic procedure: the accidental rupture of the left ventricle and the development of a secondary left ventricular pseudoaneurysm. We describe the clinical, radiological, and laboratory characteristics as well as the outcome of this case.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Primary effusion lymphoma is a very rare entity that represents 4% of non-Hodgkin\u2019s lymphoma cases associated with human immunodeficiency virus and 0.1% to 1% of all lymphomas in patients with another type of immunodeficiency in regions where human herpes virus type 8 is not endemic. This reported case is an unusual presentation of primary effusion lymphoma because it occurred in an immunocompetent human immunodeficiency virus-negative adult woman without the presence of Kaposi\u2019s sarcoma or Castleman\u2019s disease and for whom the clinical course after chemotherapy was successful. However, the rupture of the free wall of the left ventricle is a very rare catastrophic event that usually occurs after myocardial infarction. Left ventricle free wall rupture rarely goes unnoticed, but when it occurs, it leads to the development of a ventricular pseudoaneurysm in which the rupture is contained by the pericardium with an organized thrombus and an adjacent hematoma.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-019-2221-6","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:02:41Z","timestamp":1569196961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Primary effusion lymphoma in a human immunodeficiency virus-negative patient with unexpected unusual complications: a case report"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0789-9154","authenticated-orcid":false,"given":"Liliana","family":"Fern\u00e1ndez-Trujillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Vel\u00e1squez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz F.","family":"Sua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"unstructured":"Banks PW, Warnke RA. Primary effusion lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Volume 3: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. 3rd ed. Lyon: IARC Press; 2001:179\u201380.","key":"2221_CR1"},{"key":"2221_CR2","first-page":"260","volume-title":"World Health Organization Classification of Tumours. Volume 2: Haematopoietic and lymphoid tissues","author":"J Said","year":"2008","unstructured":"Said J, Cesarman E. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. World Health Organization Classification of Tumours. Volume 2: Haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 260\u20131.","edition":"4"},{"key":"2221_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cncr.23597","volume":"114","author":"A Carbone","year":"2008","unstructured":"Carbone A, Gloghini A. PEL and HHV8\u00adunrelated effusion lymphomas: classification and diagnosis. Cancer. 2008;114:225\u20137.","journal-title":"Cancer"},{"issue":"9","key":"2221_CR4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.5858\/2001-125-1246-AOPPEL","volume":"125","author":"E Lechapt-Zalcman","year":"2001","unstructured":"Lechapt-Zalcman E, Challine D, Delfau-Larue MH, Haioun C, Desvaux D, Gaulard P. Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus\u2013seronegative man. Arch Pathol Lab Med. 2001;125(9):1246\u20138.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"2221_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000326398","volume":"48","author":"M Munichor","year":"2004","unstructured":"Munichor M, Cohen H, Sarid R, Manov I, Iancu TC. Human herpesvirus 8 in primary effusion lymphoma in an HIV-seronegative male: a case report. Acta Cytol. 2004;48(3):425\u201330.","journal-title":"Acta Cytol"},{"issue":"5","key":"2221_CR6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/2000-124-0753-EPLNIO","volume":"124","author":"S Ariad","year":"2000","unstructured":"Ariad S, Benharroch D, Lupu L, Davidovici B, Dupin N, Boshoff C. Early peripheral lymph node involvement of human herpesvirus 8\u2013associated, body cavity\u2013based lymphoma in a human immunodeficiency virus\u2013negative patient. Arch Pathol Lab Med. 2000;124(5):753\u20135.","journal-title":"Arch Pathol Lab Med"},{"key":"2221_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1183\/09031936.99.14512319","volume":"14","author":"V Ascoli","year":"1999","unstructured":"Ascoli V, Scalzo CC, Danese C, Vacca K, Pistilli A, Lo Coco F. Human herpes virus-8 associated primary effusion lymphoma of the pleural cavity in HIV-negative elderly men. Eur Respir J. 1999;14:1231\u20134.","journal-title":"Eur Respir J"},{"key":"2221_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/1742-6413.56361","volume":"6","author":"F Brimo","year":"2009","unstructured":"Brimo F, Popradi G, Michel RP, Auger M. Primary effusion lymphoma involving three body cavities. Cytojournal. 2009;6:21.","journal-title":"Cytojournal"},{"key":"2221_CR9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2169\/internalmedicine.49.3587","volume":"49","author":"T Ikebe","year":"2010","unstructured":"Ikebe T, Amemiya Y, Saburi M, Ando T, Kohno K, Ogata M, Hiramatsu K, Kadota J. Rare primary effusion lymphoma associated with HHV-8 in Japan. Intern Med. 2010;49:1303\u20136.","journal-title":"Intern Med"},{"key":"2221_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3349\/ymj.2009.50.6.862","volume":"50","author":"F Ceran","year":"2009","unstructured":"Ceran F, Aydin Y, Oz\u00e7akar L, Han U, Yildiz M. Primary effusion lymphoma: an untrivial differential diagnosis for ascites. Yonsei Med J. 2009;50:862\u20134.","journal-title":"Yonsei Med J"},{"key":"2221_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ajh.20048","volume":"76","author":"E Boulanger","year":"2004","unstructured":"Boulanger E, Hermine O, Fermand JP, Radford-Weiss I, Brousse N, Meignin V, Gessain A. Human herpesvirus 8 (HHV8) associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients. Am J Hematol. 2004;76:88\u201391.","journal-title":"Am J Hematol"},{"key":"2221_CR12","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.2169\/internalmedicine.47.1565","volume":"47","author":"Y Terasaki","year":"2008","unstructured":"Terasaki Y, Okumura H, Saito K, Sato Y, Yoshino T, Ichinohasama R, Ishida Y. HHV-8\/KSHV-negative and CD20 positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab. Intern Med. 2008;47:2175\u20138.","journal-title":"Intern Med"},{"key":"2221_CR13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.5858\/arpa.2012-0294-RS","volume":"137","author":"S Patel","year":"2013","unstructured":"Patel S, Xiao P. Primary effusion lymphoma. Arch Pathol Lab Med. 2013;137:1152\u20134.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"2221_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1182\/blood.V97.3.744","volume":"97","author":"A Carbone","year":"2001","unstructured":"Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1\/IRF4, BCL-6, and CD138\/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood. 2001;97(3):744\u201351.","journal-title":"Blood"},{"issue":"10","key":"2221_CR15","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1182\/blood-2002-10-3090","volume":"101","author":"U Klein","year":"2003","unstructured":"Klein U, Gloghini A, Gaidano G, et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood. 2003;101(10):4115\u201321.","journal-title":"Blood"},{"key":"2221_CR16","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.96.8.4546","volume":"96","author":"N Dupin","year":"1999","unstructured":"Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi\u2019s sarcoma, multicentric Castlemans\u2019s disease and primary effusion lymphoma. Proc Natl Acad Sci U S A. 1999;96:4546\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2221_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/ajcp\/105.2.221","volume":"105","author":"MQ Ansari","year":"1996","unstructured":"Ansari MQ, Dawson DB, Nadro R, Rutherford C, Schneider NR, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol. 1996;105:221\u20139.","journal-title":"Am J Clin Pathol"},{"key":"2221_CR18","first-page":"1637","volume":"78","author":"J Teruya-Feldstein","year":"1998","unstructured":"Teruya-Feldstein J, Zauber P, Setsuda JE, Berman EL, Sorbara L, et al. Expression of human herpervirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman\u2019s disease and primary effusion lymphoma. Lab Invest. 1998;78:1637\u201342.","journal-title":"Lab Invest"},{"unstructured":"Labardini M\u00e9ndez JR, Cervera Ceballos E, Corrales Alfaro C, Balbuena Mart\u00ednez M, Barbosa Ibarra AA, Espinoza Zamora JR, et al. Oncogu\u00eda: linfoma no Hodgkin. Cancerologia. 2011;6:139\u201352.","key":"2221_CR19"},{"issue":"3","key":"2221_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5582\/irdr.2014.01010","volume":"3","author":"S Okada","year":"2014","unstructured":"Okada S, Goto H, Yotsumoto M. Current status of treatment for primary effusion lymphoma. Intractable Rare Dis Res. 2014;3(3):65\u201374.","journal-title":"Intractable Rare Dis Res"},{"key":"2221_CR21","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","volume":"23","author":"E Boulanger","year":"2005","unstructured":"Boulanger E, Gerard L, Gabarre J, Molina JM, Rapp C, Abino JF, Cadranel J, Chevret S, Oksenhendler E. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol. 2005;23:4372\u201380.","journal-title":"J Clin Oncol"},{"key":"2221_CR22","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1182\/blood-2002-08-2525","volume":"101","author":"SK Ghos","year":"2003","unstructured":"Ghos SK, Wood C, Boise LH, Mian AM, Deyev VV, et al. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through axidothymidine-mediated inhibition of NF-\u03baB. Blood. 2003;101:2321\u20137.","journal-title":"Blood"},{"key":"2221_CR23","volume-title":"World Health Organization Classification of Tumours. Volume 3: Pathology and genetics of tumours of haematopoietic and lymphoid tissues","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Volume 3: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. 3rd ed. Lyon: IARC Press; 2001.","edition":"3"},{"key":"2221_CR24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505043321802","volume":"332","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186\u201391.","journal-title":"N Engl J Med"},{"key":"2221_CR25","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1200\/JCO.2003.06.013","volume":"21","author":"C Simonelli","year":"2003","unstructured":"Simonelli C, Spina M, Cinelli R, et al. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol. 2003;21:3948\u201354.","journal-title":"J Clin Oncol"},{"key":"2221_CR26","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V88.8.3124.bloodjournal8883124","volume":"88","author":"JW Said","year":"1996","unstructured":"Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi\u2019s sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus negative women. Blood. 1996;88:3124\u20138.","journal-title":"Blood"},{"key":"2221_CR27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1182\/blood.V96.4.1599","volume":"96","author":"Y Aoki","year":"2000","unstructured":"Aoki Y, Yarchoan R, Braun J, Iwamoto A, Tosato G. Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood. 2000;96:1599\u2013601.","journal-title":"Blood"},{"key":"2221_CR28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1378\/chest.111.5.1403","volume":"111","author":"SL Brown","year":"1997","unstructured":"Brown SL, Gropler RJ, Harris KM. Distinguishing left ventricular aneurysm from pseudoaneurysm: a review of the literature. Chest. 1997;111:1403\u20139.","journal-title":"Chest"},{"key":"2221_CR29","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1001\/jama.1981.03320170063036","volume":"246","author":"AH Dachman","year":"1981","unstructured":"Dachman AH, Spindola-Franco H, Solomon N. Left ventricular pseudoaneurysm: its recognition and significance. JAMA. 1981;246:1951\u20133.","journal-title":"JAMA"},{"key":"2221_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0002-9149(94)90098-1","volume":"74","author":"H Pollak","year":"1994","unstructured":"Pollak H, Nobis H, Mlczoch J. Frequency of left ventricular free wall rupture complicating acute myocardial infarction since the advent of thrombolysis. Am J Cardiol. 1994;74:184\u20136.","journal-title":"Am J Cardiol"},{"doi-asserted-by":"crossref","unstructured":"Zoffoli G, Mangino D, Venturini A, Terrini A, Asta A, Zanchettin C, et al. Diagnosing left ventricular aneurysm from pseudo-aneurysm: A case report and a review in literature. J Cardiothorac Surg. 2009;4:11.","key":"2221_CR31","DOI":"10.1186\/1749-8090-4-11"},{"doi-asserted-by":"crossref","unstructured":"Gueron M, Wanderman KL, Hirsch M, Borman J. Pseudoaneurysm of the left ventricle after myocardial infarction: A curable form of myocardial rupture. J Thorac Cardiovasc Surg. 1975;69:736-42.","key":"2221_CR32","DOI":"10.1016\/S0022-5223(19)41508-0"},{"issue":"5","key":"2221_CR33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0002-9149(80)90442-7","volume":"46","author":"Robert P. Gatewood","year":"1980","unstructured":"Gatewood RP Jr, Nanda NC. Differentiation of left ventricular pseudoaneurysm from true aneurysm with two-dimensional echocardiography. Am J Cardiol. 1980;46:869-78.","journal-title":"The American Journal of Cardiology"},{"issue":"5","key":"2221_CR34","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/0002-9343(80)90271-5","volume":"68","author":"Edward Catherwood","year":"1980","unstructured":"Catherwood E, Mintz GS, Kotler MN, Kimbiris D, Lemmon W, Parry WR. Pseudoaneurysm of the left ventricle complicated by Salmonella typhimurium infection. Recognition by two-dimensional echocardiography. Am J Med. 1980;68:782-6.","journal-title":"The American Journal of Medicine"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2221-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T07:20:00Z","timestamp":1664436000000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2221-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2221"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2221-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2019,9,23]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This report was prepared in accordance with the ethical standards of the institutional ethics committee and with the 1964 Helsinki declaration. We received an approval letter to publish this manuscript from the Ethics Committee in Biomedical Research of the Fundaci\u00f3n Valle del Lili (IRB\/EC no. 282-2016).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"301"}}